Editorial: Development and Potential Mechanisms of Low Molecular Weight Drugs for Cancer Immunotherapy

Yanfeng Gao*, Xuanming Yang, Bin Zhang

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Article number920442
JournalFrontiers in immunology
StatePublished - May 17 2022


  • cancer immunotherapy
  • drug repositioning
  • immune checkpoint
  • innate immunity
  • small molecular inhibitor

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this